Clinical Trial Update: EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated the combination of EPOCH chemotherapy and bortezomib in adults with adult T-cell leukemia/lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia-Lymphoma, Adult T-Cell | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-12-13